AURORA CANNABIS INC (ACB.TO) Financials
ACB.TO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 817.2 million | 259.0 million |
2023-09-30 | 818.4 million | 314.6 million |
2023-06-30 | 832.2 million | 356.5 million |
2023-03-31 | 926.3 million | 409.2 million |
ACB.TO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -8.1 million | 2.8 million |
2023-09-30 | -35.1 million | 4.6 million |
2023-06-30 | -15.5 million | 2.3 million |
2023-03-31 | ? | ? |
ACB.TO Net Income
No data available :(
ACB.TO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 48.5 million |
2023-09-30 | 128.9 million | 80.0 million | 50.6 million |
2023-06-30 | 157.9 million | 76.9 million | 46.7 million |
2023-03-31 | 234.9 million | 80.0 million | 49.2 million |
ACB.TO Shares Outstanding
ACB.TO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.8 million | 782000 | 37.2 million | - |
2023-09-30 | 8.5 million | 946000 | 39.9 million | - |
2023-06-30 | 4.3 million | 1.1 million | 37.0 million | - |
2023-03-31 | 3.6 million | - | 43.8 million | - |
ACB.TO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 64.4 million | 44.6 million |
2023-09-30 | 63.4 million | 63.4 million |
2023-06-30 | 75.1 million | 78.9 million |
2023-03-31 | 64.0 million | 52.1 million |
ACB.TO
Price: CA$9.20
52 week price:
Earnings Per Share: -79.20 CAD
P/E Ratio: -0.07
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 2.0 million
Market Capitalization: 495.2 million